AccurKardia headquarters details
- Street address
- 101 Ave of the Americas suite 843
- City
- New York City
- State / region
- New York
- ZIP / postal code
- 10013
- Country
- United States
- Phone
- +1 718 708 3522
- Founded
- 2019
- Website
- accurkardia.com
- linkedin.com/company/accurkardia
Location map
Open in Google MapsAll AccurKardia office locations
| City | State / region | Country | Type |
|---|---|---|---|
| New York City HQ | New York | United States | Headquarters |
Showing the headquarters of 2 recorded locations. See every location in GraphIQ →
About AccurKardia
AccurKardia is headquartered in New York City, New York, United States. Founded in 2019, the company has 2 recorded locations and employs approximately 8 people worldwide.
Where is AccurKardia's main office?
AccurKardia's main headquarters office is located at 101 Ave of the Americas suite 843, New York City, New York 10013, United States. This is the company's primary corporate address.
AccurKardia contact information
The main switchboard for AccurKardia headquarters can be reached at +1 718 708 3522. Official website: accurkardia.com.
What does AccurKardia do?
AccurKardia is an ECG-led diagnostics software company transforming ECG data into a more powerful diagnostic tool and broad biomarker to improve patient outcomes and save lives globally. Its cloud-based platform includes AccurECG™, an FDA-cleared Class II software as a medical device (SaMD) that delivers fully automated, near real-time ECG interpretation and integrates seamlessly into existing clinical workflows. AccurECG™ was named “Best New ECG Technology” at the 2025 MedTech Breakthrough Awards. AccurKardia’s pipeline includes AK+ Guard™—an AI-driven hyperkalemia detection solution using Lead I ECG data to help identify life-threatening high potassium levels earlier in patients with CKD and ESRD—which received FDA Breakthrough Device Designation and acceptance into FDA’s Total Product Life Cycle (TAP) program in December 2024; and AK-AVS™, an AI model for aortic stenosis detection via 12-lead ECGs, which received FDA Breakthrough Device Designation in October 2024. AccurKardia completed the 2024 MedTech Innovator (MTI) cohort and was one of five companies selected for the American Heart Association’s inaugural Heart & Brain Health Accelerator track within MTI. AccurKardia also completed Cohort 3 of Mayo Clinic Platform_Accelerate in 2023. (AK+ Guard™ and AK-AVS™ are investigational and not commercially available.)
Frequently asked questions
Where is AccurKardia headquarters?
AccurKardia's headquarters is located at 101 Ave of the Americas suite 843, New York City, New York 10013, United States.
How many offices does AccurKardia have?
GraphIQ records 2 locations for AccurKardia, as of October 2026.
What is AccurKardia's corporate address?
The corporate headquarters address is 101 Ave of the Americas suite 843, New York City, New York 10013, United States.
When was AccurKardia founded?
AccurKardia was founded in 2019 and employs approximately 8 people.
What is AccurKardia's phone number?
The main phone number for AccurKardia headquarters is +1 718 708 3522.
How many employees does AccurKardia have?
AccurKardia has approximately 8 employees (GraphIQ estimate, 2026).